Acute Hepatitis Induced by Kava Kava

References

• Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. J Am Med Assoc 1998; 280: 1569–1575
   PubMed Web of Science ®Google Scholar
• Singh YN, Blumenthal M. Kava: an overview. Distribution, mythology, botany, culture, chemistry and pharmacology of the South Pacific's most revered herb. Herbalgram 1997; 39(suppl)34–56
   Google Scholar
• Murray M. The Healing Power of Herbs. 2nd ed., Prima, Rocklin, CA 1995; 210–219
   Google Scholar
• , Kava Drug Monograph. Denver: Micromedex, Updated Sep. 1998.
   Google Scholar
• Schulz V, Hänsel R. Rationale Phytotherapie. Springer, Berlin 1999
   Google Scholar
• Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacol (Berl) 1994; 116: 469–474
   PubMed Web of Science ®Google Scholar
• Yoshida EM, McClean CA, Cheng ES, Blanc PD, Somberg KA, Ferrell LD, Lake JR. Chinese herbal medicine, fulminant hepatitis and liver transplantation. Am J Gastroenterol 1996; 91: 2647–2648
   PubMed Web of Science ®Google Scholar
• Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, Michel H. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992; 117: 129–132
   PubMed Web of Science ®Google Scholar
• Pillans PI, Eade MN, Massey RJ. Herbal medicine and toxic hepatitis. NZ Med J 1994; 107: 432–433
   PubMedGoogle Scholar
• Woolf GM, Petrovic LM, Rojter SE, Wainwright S, Villamil FG, Katkov WN, Michieletti P, Wanless IR, Stermitz FR, Beck JJ, Vierling JM. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Intern Med 1994; 121: 729–735
   PubMed Web of Science ®Google Scholar
• Anderson IB, Mullen WH, Meeker JE, Khojasteh-Bakht SC, Oishi S, Nelson SD, Blanc PD. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996; 124: 726–734
   PubMed Web of Science ®Google Scholar
• Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157: 913–919
   PubMed Web of Science ®Google Scholar
• Valla D, Benhamou JP. Drug-induced vascular and sinusoidal lesions of the liver. Clin Gastroenterol 1988; 2: 481–500
   Google Scholar
• Lekehal M, Pessayre D, Lereau JM, Moulis C, Foraste I, Fau D. Hepatotoxicity of the herbal medicine, germander: metabolic activation of its furano diterpinoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996; 24: 212–218
   PubMed Web of Science ®Google Scholar
• Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157: 913–919
   PubMed Web of Science ®Google Scholar
• Escher M, Desmeules J, Giostra E, Mentha G. Drug points: hepatitis associated with Kava, a herbal remedy for anxiety. Br Med J 2001; 322: 139
   PubMed Web of Science ®Google Scholar
• Mathews JD, Riley MD, Fejo L, Munoz E, Milns N, Gardner ID, Powers JR, Ganygulpa E, Gununuwawuy BJ. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. Med J Aust 1988; 148: 548–555
   PubMed Web of Science ®Google Scholar
• Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal medication. Dtsch Med Wochenschr 1998; 123: 1410–1414
   PubMed Web of Science ®Google Scholar
• Duffield AM, Jamieson DD, Lidgard RO, Duffield PH, Bourne DJ. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 1989; 475: 273–281
   PubMed Web of Science ®Google Scholar
• Russmann S, Lauterburg B, Helbling A. Kava hepatotoxicity. Ann Intern Med 2001; 135: 68–69
   PubMed Web of Science ®Google Scholar
• Fetrow CW, Avila JR. Professional's Handbook of Complementary and Alternative Medicines. Springhouse, Springhouse, PA 1999
   Google Scholar
• Ernst E. Second thoughts about safety of St John's wort. Lancet 1999; 354: 2014–2016
   PubMed Web of Science ®Google Scholar
• Mai I, Kruger H, Budde K, Johne A, Brockmoller J, Neumayer HH, Roots I. Hazardous pharmacokinetic interaction of Saint John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int J Clin Pharmacol Ther 2000; 38: 500–502
   PubMed Web of Science ®Google Scholar
• Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000; 294: 88–95
   PubMed Web of Science ®Google Scholar
• Miller LG. Herbal medicinals. Arch Intern Med 1998; 138: 2200–2211
   Google Scholar
• Mann C, Staba EJ. The chemistry, pharmacology, and commercial formulations of chamomile. Herbs, Spices, and Medicinal Plants: Recent Advances in Botany, Horticulture, and Pharmacology, LE Craker, JE Simon. Oryx Press, Phoenix, AZ 1986; Vol. 1: 235–280
   Google Scholar